186 related articles for article (PubMed ID: 35721086)
1. Trends in Uveal Melanoma Presentation and Survival During Five Decades: A Nationwide Survey of 3898 Swedish Patients.
Gill V; Herrspiegel C; Sabazade S; Fili M; Bergman L; Damato B; Seregard S; Stålhammar G
Front Med (Lausanne); 2022; 9():926034. PubMed ID: 35721086
[TBL] [Abstract][Full Text] [Related]
2. Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973-2012).
Mahendraraj K; Lau CS; Lee I; Chamberlain RS
Clin Ophthalmol; 2016; 10():2113-2119. PubMed ID: 27822007
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy.
Wang H; Zhang R; Wang Y; Chen R; Liu Y; Li Y; Wei W
BMC Ophthalmol; 2022 Apr; 22(1):163. PubMed ID: 35397506
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics of UM and Association of Metastasis of Uveal Melanoma with Congenital Oculocutaneous Melanosis in Asian Patients: Analysis of 1151 Consecutive Eyes.
Zhou N; Zhang R; Liu Y; Wei W
Ophthalmol Retina; 2021 Nov; 5(11):1164-1172. PubMed ID: 33444806
[TBL] [Abstract][Full Text] [Related]
6. A Prognostic Score for the Prediction of Local Treatment Failure in Plaque Brachytherapy of Uveal Melanoma.
Kal Omar R; Hagström A; Dahlander S; Carlsson Tedgren Å; Stålhammar G
Adv Radiat Oncol; 2023; 8(3):101152. PubMed ID: 36896210
[TBL] [Abstract][Full Text] [Related]
7. Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time.
Roelofsen CDM; Wierenga APA; van Duinen S; Verdijk RM; Bleeker J; Marinkovic M; Luyten GPM; Jager MJ
Ocul Oncol Pathol; 2021 Mar; 7(2):133-141. PubMed ID: 33981696
[TBL] [Abstract][Full Text] [Related]
8. No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter.
Sabazade S; Herrspiegel C; Gill V; Stålhammar G
BMC Cancer; 2021 Nov; 21(1):1270. PubMed ID: 34819035
[TBL] [Abstract][Full Text] [Related]
9. Incidence and mortality of uveal melanoma in Australia (1982-2014).
Beasley AB; Preen DB; McLenachan S; Gray ES; Chen FK
Br J Ophthalmol; 2023 Mar; 107(3):406-411. PubMed ID: 34880052
[TBL] [Abstract][Full Text] [Related]
10. [The clinical observation of external scleral plaque radiotherapy in patients with uveal melanoma].
Liu YM; Zhou N; Wei WB; Wang P
Zhonghua Yan Ke Za Zhi; 2020 Sep; 56(9):670-675. PubMed ID: 32907299
[No Abstract] [Full Text] [Related]
11. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma and uveal melanoma in Jordan: incidence, demographics, and survival (2011-2020).
Yousef YA; Mohammad M; Al-Nawaiseh I; Mahafza H; Halalsheh H; Mehyar M; AlJabari R; Al-Rawashdeh K; Jaradat I; Sultan I; Al-Hussaini M
Ophthalmic Genet; 2023 Apr; 44(2):119-126. PubMed ID: 35848346
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
15. Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period.
Tong TML; Bastiaannet E; Speetjens FM; Blank CU; Luyten GPM; Jager MJ; Marinkovic M; Vu THK; Rasch CRN; Creutzberg CL; Beenakker JM; Hartgrink HH; Bosch JJJ; Kiliç E; Naus NC; Yavuzyigitoglu S; van Rij CM; Burgmans MC; Kapiteijn EHW
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001679
[TBL] [Abstract][Full Text] [Related]
16. Scleral necrosis in patients with posterior uveal melanomas evaluated by transcleral fine needle aspiration biopsy and treated by 125I plaque.
Correa ZM; Huth B; Augsburger JJ
Arq Bras Oftalmol; 2018; 81(4):330-335. PubMed ID: 29995126
[TBL] [Abstract][Full Text] [Related]
17. Clinical management of uveal melanoma: a comprehensive review with a treatment algorithm.
Sayan M; Mamidanna S; Oncel D; Jan I; Vergalasova I; Weiner J; Ohri N; Acikalin B; Chundury A
Radiat Oncol J; 2020 Sep; 38(3):162-169. PubMed ID: 33012143
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and prognostic factors of 1 166 patients with uveal melanoma].
Luo JT; Yang YH; Liu YM; Li Y; Wei WB
Zhonghua Yan Ke Za Zhi; 2022 Jul; 58(7):529-534. PubMed ID: 35796126
[No Abstract] [Full Text] [Related]
19. Incidence of uveal melanoma in Sweden from 1960 to 1998.
Bergman L; Seregard S; Nilsson B; Ringborg U; Lundell G; Ragnarsson-Olding B
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2579-83. PubMed ID: 12147588
[TBL] [Abstract][Full Text] [Related]
20. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
